iTeh StandardsiTeh Standards
EURUSD
Your shopping cart is empty.
CEN

EN ISO 13408-6:2011/A1:2013

(Amendment)

Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2005/Amd 1:2013)

Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2005/Amd 1:2013)

2012-10-15 GVN: Draft for // vote received in ISO/CS (see notification of 2012-10-12 in dataservice).
2012-01-19 EMA: Draft for // ENQ received in ISO/CS (see notification of 2012-01-18).

Aseptische Herstellung von Produkten für die Gesundheitsfürsorge - Teil 6: Isolatorensysteme (ISO 13408-6:2005/Amd 1:2013)

Traitement aseptique des produits de santé - Partie 6: Systèmes isolateurs (ISO 13408-6:2005/Amd 1:2013)

Aseptična proizvodnja izdelkov za zdravstveno nego - 6. del: Sistemi izolatorjev - Dopolnilo A1 (ISO 13408-6:2005/Amd 1:2013)

Ta del ISO 13408 določa zahteve za sisteme izolatorjev, uporabljene za aseptično proizvodnjo, in ponuja smernice za kvalifikacijo, biodekontaminacijo, validacijo, delovanje in nadzor sistemov izolatorjev, uporabljenih za aseptično proizvodnjo izdelkov za zdravstveno nego. Ta del ISO 13408 je osredotočen na uporabo sistemov izolatorjev za vzdrževanje aseptičnih pogojev; to lahko vključuje uporabo nevarnih materialov. Ta del ISO 13408 ne nadomešča ali zamenjuje nacionalnih regulatornih zahtev, kot so dobre prakse proizvodnje (GMP) in/ali strnjene zahteve, ki se nanašajo na nekatere državne ali regijske pristojnosti.

General Information

Status
Withdrawn
Publication Date
19-Mar-2013
Withdrawal Date
18-May-2021
ICS
11.080.01 - Sterilization and disinfection in general
Technical Committee
CEN/TC 204 - Sterilization of medical devices
Drafting Committee
CEN/TC 204 - Sterilization of medical devices
Current Stage
9960 - Withdrawal effective - Withdrawal
Completion Date
19-May-2021
Directive
90/385/EEC - Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices
93/42/EEC - Council Directive 93/42/EEC of 14 June 1993 concerning medical devices
98/79/EC - Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices
Mandate
M/BC/CEN/89/9 - Joint Standardization request to CEN/CENELEC concerning harmonized standards relating to horizontal aspects in the field of medical devices
Ref Project
SIST EN ISO 13408-6:2011/A1:2013 - Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2005/Amd 1:2013)

Relations

Replaced By
EN ISO 13408-6:2021 - Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2021)
Effective Date
26-May-2021
Amends
EN ISO 13408-6:2011 - Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2005)
Effective Date
08-Jun-2022

Buy Standard

EN ISO 13408-6:2011/A1:2013EN ISO 13408-6:2011/A1:2013
PreviousNext
Amendment
EN ISO 13408-6:2011/A1:2013
English language
13 pages
sale 10% off
Preview
sale 10% off
Preview
e-Library read for
1 day

Standards Content (Sample)

SLOVENSKI STANDARD
SIST EN ISO 13408-6:2011/A1:2013
01-junij-2013
$VHSWLþQDSURL]YRGQMDL]GHONRY]D]GUDYVWYHQRQHJRGHO6LVWHPLL]RODWRUMHY
'RSROQLOR$ ,62$PG
Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-
6:2005/Amd 1:2013)
Aseptische Herstellung von Produkten für die Gesundheitsfürsorge - Teil 6:
Isolatorensysteme (ISO 13408-6:2005/Amd 1:2013)
Traitement aseptique des produits de santé - Partie 6: Systèmes isolateurs (ISO 13408-
6:2005/Amd 1:2013)
Ta slovenski standard je istoveten z: EN ISO 13408-6:2011/A1:2013
ICS:
11.080.01 Sterilizacija in dezinfekcija na Sterilization and disinfection
splošno in general
SIST EN ISO 13408-6:2011/A1:2013 en
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

---------------------- Page: 1 ----------------------

SIST EN ISO 13408-6:2011/A1:2013

---------------------- Page: 2 ----------------------

SIST EN ISO 13408-6:2011/A1:2013


EUROPEAN STANDARD
EN ISO 13408-6:2011/A1

NORME EUROPÉENNE

EUROPÄISCHE NORM
March 2013
ICS 11.080.01
English Version
Aseptic processing of health care products - Part 6: Isolator
systems (ISO 13408-6:2005/Amd 1:2013)
Traitement aseptique des produits de santé - Partie 6: Aseptische Herstellung von Produkten für die
Systèmes isolateurs (ISO 13408-6:2005/Amd 1:2013) Gesundheitsfürsorge - Teil 6: Isolatorensysteme (ISO
13408-6:2005/Amd 1:2013)
This amendment A1 modifies the European Standard EN ISO 13408-6:2011; it was approved by CEN on 7 March 2013.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for inclusion of this
amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical references concerning such
national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN member.

This amendment exists in three official versions (English, French, German). A version in any other language made by translation under the
responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the same status as the
official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United
Kingdom.





EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

Management Centre: Avenue Marnix 17, B-1000 Brussels
© 2013 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 13408-6:2011/A1:2013: E
worldwide for CEN national Members.

---------------------- Page: 3 ----------------------

SIST EN ISO 13408-6:2011/A1:2013
EN ISO 13408-6:2011/A1:2013 (E)
Contents Page
Foreword .3
Annex ZA (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 90/385/EEC on Active Implantable Medical Devices .4
Annex ZB (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 93/42/EEC on Medical Devices .5
Annex ZC (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 98/79/EC on in vitro diagnostic medical devices .6

2

---------------------- Page: 4 ----------------------

SIST EN ISO 13408-6:2011/A1:2013
EN ISO 13408-6:2011/A1:2013 (E)
Foreword
This document (EN ISO 13408-6:2011/A1:2013) has been prepared by Technical Committee ISO/TC 198
“Sterilization of health care products” in collaboration with Technical Committee CEN/TC 204 “Sterilization of
medical devices” the secretariat of which is held by BSI.
This Amendment to the European Standard EN ISO 13408:2011 shall be given the status of a national
standard, either by publication of an identical text or by endorsement, at the latest by September 2013, and
conflicting national standards shall be withdrawn at the latest by September 2013.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. CEN [and/or CENELEC] shall not be held responsible for identifying any or all such patent rights.
This document has been prepared under a mandate given to CEN by the European Commission and the
European Free Trade Association, and supports essential requirements of EU Dir
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

This May Also Interest You

CEN
EN ISO 17664-2:2023(Main)
Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices - Part 2: Non-critical medical devices (ISO 17664-2:2021)
SIST EN ISO 17664-2:2024

This document specifies requirements for the information to be provided by the medical device manufacturer for the processing of non-critical medical devices not intended to be sterilized (i.e. a medical device that is intended to come into contact with intact skin only or a medical device not intended for direct patient contact).
This includes information for processing prior to use or reuse of the medical device.
Processing instructions are not defined in this document. Rather, this document specifies requirements to assist manufacturers of medical devices in providing detailed processing instructions that consist of the following activities, where applicable:
a)   preparation before processing;
b)   cleaning;
c)   disinfection;
d)   drying;
e)   inspection and maintenance;
f)    packaging;
g)   storage;
h)   transportation.
This document excludes processing of:
1)   critical and semi-critical medical devices;
2)   medical devices intended to be sterilized;
3)   textile medical devices used in patient draping systems or surgical clothing;
4)   medical devices specified by the manufacturer for single use only and supplied ready for use.
NOTE     See Annex E for further guidance on the application of the ISO 17664 series to a medical device.

  • Standard
    34 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 13004:2023(Main)
Sterilization of health care products - Radiation - Substantiation of selected sterilization dose: Method VDmaxSD (ISO 13004:2022)
SIST EN ISO 13004:2023

Adoption of ISO 13004:2022 – This is currently in FDIS and will be publishing in October 2022.
This document describes a method for substantiating a selected sterilization dose of 17,5,
20, 22,5, 27,5, 30, 32,5 or 35 kGy that achieves a sterility assurance level (SAL) of 10−6 or less for radiation
sterilization of health care products. This Technical Specification also specifies a method of sterilization
dose audit used to demonstrate the continued effectiveness of the substantiated sterilization dose.
NOTE Selection and substantiation of the sterilization dose is used to meet the requirements for establishing
the sterilization dose within process definition in ISO 11137-1.

  • Standard
    63 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
CEN ISO/TS 11137-4:2023(Main)
Sterilization of health care products - Radiation - Part 4: Guidance on process control (ISO/TS 11137-4:2020)
SIST-TS CEN ISO/TS 11137-4:2023

This document provides additional guidance to that given in ISO 11137-3 on meeting the requirements specified in ISO 11137-1, ISO 11137-2 and ISO/TS 13004 for the establishment and control of a radiation sterilization process using gamma, electron beam, and X-irradiation.

  • Technical specification
    64 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11137-2:2015/A1:2023(Amendment)
Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose - Amendment 1 (ISO 11137-2:2013/Amd 1:2022)
SIST EN ISO 11137-2:2015/A1:2023

2022-06-21 - lack of compliance - publication on hold

  • Amendment
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 25424:2019/A1:2022(Amendment)
Sterilization of health care products - Low temperature steam and formaldehyde - Requirements for development, validation and routine control of a sterilization process for medical devices - Amendment 1 (ISO 25424:2018/Amd 1:2022)
SIST EN ISO 25424:2020/A1:2022

2022-01-13 - TC decision is missing to skip FV - publication on hold.

  • Amendment
    15 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 17664-1:2021(Main)
Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices - Part 1: Critical and semi-critical medical devices (ISO 17664-1:2021)
SIST EN ISO 17664-1:2021

This document specifies requirements for the information to be provided by the medical device manufacturer for the processing of critical or semi-critical medical devices (i.e. a medical device that enters normally sterile parts of the human body or a medical device that comes into contact with mucous membranes or non-intact skin) or medical devices that are intended to be sterilized.
This includes information for processing prior to use or reuse of the medical device.
Processing instructions are not defined in this document. Rather, this document specifies requirements to assist manufacturers of medical devices in providing detailed processing instructions that consist of the following activities, where applicable:
a) initial treatment at the point of use;
b) preparation before cleaning;
c) cleaning;
d) disinfection;
e) drying;
f) inspection and maintenance;
g) packaging;
h) sterilization;
i) storage;
j) transportation.
This document excludes processing of the following:
—    non-critical medical devices unless they are intended to be sterilized;
—    textile devices used in patient draping systems or surgical clothing;
—    medical devices specified by the manufacturer for single use only and supplied ready for use.
NOTE       See ISO 17664-2:2021, Annex E, for further guidance on the application of the ISO 17664 series to a medical device.

  • Standard
    34 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 14160:2021(Main)
Sterilization of health care products - Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives - Requirements for characterization, development, validation and routine control of a sterilization process for medical devices (ISO 14160:2020)
SIST EN ISO 14160:2021

This document specifies requirements for the characterization of a liquid chemical sterilizing agent and for the development, validation, process control and monitoring of sterilization by liquid chemical sterilizing agents of single-use medical devices comprising, in whole or in part, materials of animal origin.
This document covers the control of risks arising from contamination with bacteria and fungi by application of a liquid chemical sterilization process. Risks associated with other microorganisms can be assessed using other methods (see NOTE 1).
This document is not applicable to material of human origin.
This document does not describe methods for the validation of the inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (see NOTE 2 and NOTE 3).
This document does not describe methods for validation of the inactivation or elimination of protozoa and parasites.
The requirements for validation and routine control described in this document are only applicable to the defined sterilization process of a medical device, which is performed after the manufacturing process, and do not take account of the lethal effects of other bioburden reduction steps (see NOTE 4).
This document does not specify tests to establish the effects of any chosen sterilization process upon the fitness for use of the medical device (see NOTE 5).
This document does not cover the level of residual sterilizing agent within medical devices (see NOTE 6).
Guidance for the characterization of a liquid chemical sterilizing agent and for the development, validation, process control and monitoring of sterilization by liquid chemical sterilizing agents of single-use medical devices comprising, in whole or in part, materials of animal origin is provided in informative Annex A.
NOTE 1  The prior application of risk management principles to medical devices utilizing animal tissues, as described in ISO 22442-1 is important. ISO 18362 provides information on control of microbial risks during processing of cell-based health-care products.
NOTE 2  Liquid chemical sterilizing agents traditionally employed to sterilize animal tissues in medical devices might not be effective in inactivating the causative agents of TSE such as bovine spongiform encephalopathy (BSE), or scrapie. Satisfactory validation in accordance with this document does not necessarily demonstrate inactivation of infective agents of this type. Risk controls related to sourcing, collection and handling of animal materials are described in ISO 22442-2.
NOTE 3  The validation of the inactivation, elimination, or elimination and inactivation of viruses and TSE agents is described in ISO 22442-3.
NOTE 4  Manufacturing processes for medical devices containing animal tissues frequently include exposure to chemical agents which can significantly reduce the bioburden on the medical device. Following the manufacturing process, a medical device is exposed to a specified sterilization process.
NOTE 5  Such testing is a crucial part of the design and development of a medical device.
NOTE 6  ISO 10993-17 specifies a method to establish allowable limits for residues of sterilizing agents.
NOTE 7  Standards for quality management systems (see ISO 13485) can be used in the control of all stages of manufacture including the sterilization process.

  • Standard
    50 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11737-1:2018/A1:2021(Amendment)
Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products - Amendment 1 (ISO 11737-1:2018/Amd 1:2021)
SIST EN ISO 11737-1:2018/A1:2021
  • Amendment
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 13408-6:2021(Main)
Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2021)
SIST EN ISO 13408-6:2021

This document specifies the requirements for and provides guidance on the specification, selection, qualification, bio-decontamination, validation, operation and control of isolator systems related to aseptic processing of health care products and processing of cell-based health care products.
This document does not specify requirements for restricted access barrier systems (RABS).
This document does not supersede or replace national regulatory requirements such as Good Manufacturing Practices (GMPs) and/or compendia requirements that pertain in particular to national or regional jurisdictions.
This document does not specify requirements for isolators used for sterility testing; however, some of the principles and information in this document could be applicable to this application.
This document does not define biosafety containment requirements.

  • Standard
    39 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11737-2:2020(Main)
Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process (ISO 11737-2:2019)
SIST EN ISO 11737-2:2020

1.1    This document specifies the general criteria for tests of sterility on medical devices that have been exposed to a treatment with the sterilizing agent which has been reduced relative to that anticipated to be used in routine sterilization processing. These tests are intended to be performed when defining, validating or maintaining a sterilization process.
1.2    This document is not applicable to:
a)    sterility testing for routine release of product that has been subjected to a sterilization process,
b)    performing a test for sterility (see 3.12),
NOTE 1    The performance of a) or b) is not a requirement of ISO 11135, ISO 11137-1, ISO 11137-2, ISO 14160, ISO 14937, ISO 17665-1 or ISO 20857.
c)    test of sterility or test for sterility for demonstration of product shelf life, stability and/or package integrity, and
d)    culturing of biological indicators or inoculated products.
NOTE 2    Guidance on culturing biological indicators is included in ISO 11138-7.

  • Standard
    35 pages
    English language
    sale 10% off
    e-Library read for
    1 day